Emile Voest
25-04-2023
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.
Back to newsMore news
Hartwig visit to Jackson Laboratory in Farmington, CT
07-06-2024
For interpretation of molecular results, Hartwig relies on the CKB resource that has been developed by The Jackson Laboratory, and …
Join us for an evening of Healthcare Tech innovation with Hartwig Medical Foundation and GCUG
24-06-2024
Calling all software developers and tech enthusiasts 🚀 Hartwig Medical Foundation partners with Google Cloud User Group (GCUG) to bring …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
11-08-2022
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.
Patient